How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?

Luis Masana, Nuria Plana, Sofia Pérez-Calahorra, Daiana Ibarretxe, Itziar Lamiquiz-Moneo, Juan Pedro-Botet, Manuel Suárez-Tembra, Pedro Valdivielso, Emilio Ortega, Fernando Civeira

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'How many familial hypercholesterolemia patients are eligible for PCSK9 inhibition?'. Together they form a unique fingerprint.

Medicine & Life Sciences